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ABSTRACT - Human cryoprecipitated plasma can form an extractable coagulum which will 
effectively remove renal calculi in selected cases. We successfully used this blood product and a 
simplified injection technique in 30 patients undergoing surgery fn- upper tract calculi. Coagulum 
pyelolithotomy was performed in 24 cases with removal of all stones in 23 (96 per cent). In 6 patients 
incomplete stone removal by conventional operative methods was successfully completed by using 
the coagulum as an adjunctive procedure. In 10 of the 30 cases (33 per cent) radiographically 
“silent” calculi were recovered within the cryoprecipitate clot. The advantages of cryoprecipitate 
over previously reported blood products, certain technical simplifications, and the appropriate 
clinical indications fm the coagulum procedure are discussed. 
The removal of renal calculi by an extractable 
cast of the collecting system was first described 
in 1943 using pooled human fibrinogen and 
clotting globulin. ’ The technique was not widely 
used because of technical complexity, limited 
availability of the fibrinogen product, and a sig- 
nificant risk of hepatitis transmission. Several 
different blood products, formulations, and 
technical modifications have since been pro- 
posed. 2-4 
We recently investigated human plasma and 
cryoprecipitated plasma for potential use in 
coagulum formation. 5 Plasma alone did not form 
a coagulum of consistent or adequate strength to 
attempt calculi removal. However, cryopre- 
cipitate when mixed with bovine thrombin and 
calcium chloride in a 1:2: 1 ratio at body 
temperature formed a consistent coagulum of 
reproducible strength. Furthermore, it com- 
pared favorably to the strength of coagula 
formed with previously reported blood products 
and formulas. We also found the cryoprecipitate 
clot dissolved within twenty-four hours when 
submerged in sterile or infected urine. Simi- 
larly, instillation and removal of the cryoprecipi- 
tate coagulum in canine kidneys resulted in no 
untoward anatomic or physiologic changes in 
function. 
Encouraged by our findings of safety, limited 
risk of hepatitis transmission in a readily avail- 
able blood product, and a simplified operative 
method which evolved during our studies on 
dogs, we applied the cryoprecipitate coagulum 
to selected clinical cases, the results of which 
are herein reported. 
Material and Methods 
Thirty patients ranging in age from twenty- 
eight to seventy-six years, 12 females and 18 
males, underwent surgery for upper tract calculi 
indicated for obstruction, persistent pain, or 
infection. In 24 patients the coagulum tech- 
nique alone was used to extract the calculi. In 
2 of the 24 patients an ipsilateral upper-third 
ureterolithotomy was performed prior to 
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coagulum pyelolithotomy. In the remaining 6 
patients the cryoprecipitate clot was used as an 
adjunct to more conventional renal calculus 
operative procedures: anatrophic nephro- 
lithotomy (5 patients), Gil-Vernet extended 
pyelolithotomy with heminephrectomy (1 
patient). 
The cases of primary coagulum pyelolithotomy 
were performed using the simplified injection 
technique and cryoprecipitate formula which 
we have reported previously5 (Fig. 1). After 
appropriate dilutions as summarized in Table I, 
cryoprecipitate, bovine thrombin, and calcium 
chloride are placed into separate sterile syringes 
and placed in an intraoperative waterbath at 
37” c. 
While the constituent solutions are warming 
in the waterbath, appropriate exposure of the 
renal pelvis is secured, and a single 16-gauge 
angiocatheter is inserted proximal to the 
ureteropelvic junction. When a proximal 
ureterolithotomy is necessary prior to the 
pyelonephrolithotomy, a 14 F red Robinson 
catheter can be used. It is inserted through the 
ureterotomy and directed proximally into the 
renal pelvis. With either method, the ureter is 
occluded with polyethylene tubing. The 
pyelocalyceal system is then filled by injecting 
saline through the angiocatheter or the Robin- 
son catheter. When the pelvis is distended and 
tense, the volume is recorded and the saline is 
aspirated. The volume of cryoprecipitate and 
corresponding concentrations of bovine thrombin 
and calcium chloride necessary for proper 
coagulum formation thus can be calculated. This 
formulation is based on the measured pyelo- 
calyceal volume and the ratio of 1 cc. cryo- 
precipitate to 2 units thrombin to 1 mg. calcium 
chloride (Table II). 
As outlined in Table I, the waterbath solu- 
tions are then transferred to sterile beakers on 
the operative field. The calculated volume of 
cryoprecipitate is aspirated into a sterile syringe. 
The corresponding thrombin and calcium 
chloride concentrations are drawn up and 
combined in a second syringe. This thrombin- 
calcium chloride solution is injected into the 
syringe containing the cryoprecipitate (Fig. 1B). 
This syringe is inverted a couple of times to 
ensure mixture, and the contents are injected via 
the angiocatheter within thirty seconds. After 
three minutes a pyelotomy is made and the 
coagulum withdrawn. An intraoperative radio- 
graph of the clot is obtained in each case to 
confirm entrapment and removal of all calculi. 
The patients undergoing anatrophic nephro- 
lithotomy and extended pyelolithotomy also 
had the cryoprecipitate solution injected via an 
angiocatheter placed in the renal pelvis. The 
clot was extracted through nephrotomy in 1 
patient and pyelotomy in the other 5 cases. 
Results 
No serious postoperative complications were 
encountered, and drains were removed by the 
tenth postoperative day. Disruption of the 
coagulum during extraction with retention of a 
clot fragment was not encountered. Failure of 
coagulum formation did not occur. 
Twenty-three of 24 patients undergoing 
primary coagulum pyelolithotomy had complete 
entrapment of all calculi within the clot that was 
removed (96 per cent). The failure occurred in 
1 patient when the coagulum removed only two 
out of three calculi. The retained calculus was 
trapped in a calyx with a stenotic infundibulum. 
Retrospectively, this represented an anatomic 
limitation of the coagulum when used as the 
only surgical technique, namely, a calyceal 
calculus larger than the infundibulum draining it. 
In 6 of these 24 cases radiographically 
“silent” calculi (stones not seen on preoperative 
films) were found within the coagulum (25 per 
cent). An example of primary coagulum pyelo- 
lithotomy and extraction of unexpected calculi is 
shown in Figure 2. Three of the 5 patients 
undergoing anatrophic nephrolithotomy and 
adjunctive coagulum extraction had “silent” 
calculi, fragments, or debris entrapped in the 
clot (Fig. 3). Similarly, the patient who under- 
went extended pyelolithotomy with coagulum 
also demonstrated several unexpected calculi 
(Fig. 4). The heminephrectomy was performed 
because of segmental lower pole parenchymal 
atrophy and punctate calcifications within the 
papilla which were confirmed microscopically 
in the operative specimen. 
The over-all incidence of “silent” stone re- 
trieval directly attributable to the use of the 
coagulum technique, was 10 out of 30 (33 per 
cent). Each patient had postoperative plain films 
of the abdomen showing no residual calculi 
except for the patient in whom the procedure 
failed because of an anatomic limitation. Post- 
operative serum creatinine in each patient re- 
mained unchanged from preoperative values. 
Excretory urograms were obtained in 21 of the 
30 patients, and each demonstrated prompt 
function and no structural aberrations attributable 
to the coagulum procedure. 
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TABLE I. Preparation of coagulum constituents 
1. CaCl2: 1 gram per 10 ml (Upjohn ampoule) = 100 mg/cc. 
a) aspirate contents into a sterile 10 cc. syringe and drop into waterbath 
b) warm at 37 o C for 10 minutes 
c) transfer contents into sterile beaker on operative field 
d) draw required volume directly with a sterile tuberculin syringe - 
.25 cc. = 25 mg CaCl2 
2. Topical Bovine Thrombin: 5000 units/vial (Parke-Davis) + 5 cc. of standard diluent 
= 1000 units/cc. 
a) draw up 1 cc. and add 9 cc. saline (in a sterile 10 cc. syringe) = (100 
units/cc.) 
b) put this syringe into waterbath 
c) warm at 37” C for 10 minutes 
d) transfer contents into sterile beaker on operative field 
e) draw required volume with a sterile tuberculin syringe 
thrombin 
.5 cc. = 50 units 
3. Cryoprecipitate - arrives from the blood bank thawed to room temperature 
a) aspirate contents of enough packets to fill one sterile 50 cc. syringe and 
drop into waterbath 
b) warm at 37” C for 10 minutes 
c) transfer contents into sterile beaker on operative field 
d) draw required volume into a sterile syringe* 
4. The contents of the tuberculin syringes (thrombin - CaC12) are combined in a sterile 
3 cc. syringe ** 






FIGURE 1. (A) and@) S 4 e uence of cyoprecipitate coagulum technique. 
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TABLE II. Cryoprecipitate coaguhm formulation 
Ratio of 1 ml CrvooreciDitate to 2 units Thrombin to 1 mo Calcium Chloride is maintained regardless 
” 





















Requires mg CaC 12 
(100 mglcc.) 
9 9 (.lOcc.) 
14 14 (.15) 
19 19 (.20) 
24 24 (.25) 
28 26 t.30) 
33 33 1.35) 
38 38 t.40) 
43 43 (.45) 
48 48 t.50) 
53 53 l.55) 
58 56 1.60) 
63 63 t.65) 
68 68 L70) 
72 72 t.75) 
77 77 t.80) 




















[Q.S. with normal saline to make 1.2 or 3ml] 
’ “STEP1 STEP 2 
Measure Pyelocalyceal 
volume. e. g. 20 ml 
STEP 3 
I : 2 : I ratio 
Operative field 
STEP 4 
Mix and inject 
over 30 seconds 
through angiocath 
Cryuprecipitate CaCl2 Thrombin 
(100 mglccl wo u/cc) 
Place in waterbath set at 37OC 
19cc Cryoprecipitate 38 units thrombin (. 4cc) 
* 19 mg CaCl2 (. Xc) 
I Q. S. normal saline 
to make ICC L 4cc) I 
** 
FIGURE 1. Continued. 
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FIGURE 2. Thirty-six-year-old black 
man with hyperparathyroidism compli- 
cated by impacted left ureteral and upper 
tract calculi underwent combined uretero- 
lithotomy and coagulum pyelolithotomy. 
(A) Preoperative plainfilm; (B) radiograph 
of extracted coagulum showing 2 “silent” 
calculi; (C) postoperative plain film shows 
no residual calculi. 
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FIGURE 3. Thirty-four- 
year-old white man with 
obstructing left ureteral 
and several free-floating 
calculi in upper tract 
underwent ureterolithotomy 
followed by injection of 
coagulum solutions into 
Robinson catheter directed 
into renal pelvis via ure- 
terotomy. Coagulum ex- 
tracted through lower pole 
nephrotomy. (A) Preopera- 
tive plain film; (B) extracted 
coagulum; (C) radiograph 
of coagulum showing all 
calculi entrapped, includ- 
ing 3 unexpected stones; 
(D) postoperative plain 
film shows no residual 
calculi. 
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Comment 
A successful extraction rate of 96 per cent 
when using the coagulum for pyelolithotomy is 
gratifying and reflects proper selection of cases 
wherein favorable anatomic conditions exist, 
such as pyelocalyceal dilatation. This is best 
exemplified by our failure where a narrowed 
infundibulum did not allow extraction of a 
larger calyceal calculus. 
Our 6 additional cases prove that the coagulum 
method can be a very useful adjunct to other 
renal stone procedures by allowing more com- 
plete evacuation of calculi. This is particularly 
true for small, free-floating stones, fragments, 
or poorly matured amorphous debris which 
otherwise would be difficult or impossible to 
FIGURE 4. Fifty-six-year- 
old white man with ob- 
structing right uretero- 
pelvic junction calculus 
and several calculi in lower 
pole collecting system 
underwent coagulum pyelo- 
lithotomy. (A) Preoperative 
one-minute nephrogram; 
(B) extracted coagulum; 
(C) radiograph of coagulum 
with several unexpected 
calculi; (D) postoperative 
plain film shows no residual 
calculi. 
localize accurately or remove. Occasionally an 
obstructing proximal ureteral calculus will be 
associated with additional upper tract calculi. If 
these stones are small or difficult to reach, only 
a ureterolithotomy normally would be per- 
formed. However, with the coagulum, these 
stones can be removed by combining a coagu- 
lum pyelolithotomy with the ureterolithotomy 
(Figs. 2 and 3). 
The 33 per cent incidence of “silent” calculi 
within coagula is perhaps surprising but punctu- 
ates the potential frequency with which un- 
suspected calculi can occur. Virtually all of these 
additional stones were small (3 to 5 mm.) and, 
if left behind, could represent the nidus for 
persistent, recurrent, or progressive calculus 
formation. Thus, the cryoprecipitate technique 
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offers a new dimension to all forms of renal 
calculus surgery where the hallmark remains 
the removal of all stones and debris. 
As described in our earlier study,5 cryopre- 
cipitate offers several advantages over previously 
reported blood products. It is available in 
virtually all blood banks and can be thawed 
in fifteen minutes, ready for use. All packets 
are screened for hepatitis B antigen by radio- 
immunoassay, and in many centers controlled 
donors who are known to be hepatitis-free 
provide the source for cryoprecipitate. Certainly 
the risk of hepatitis transmission is no greater 
than in a standard blood transfusion. 
Autogenous cryoprecipitate can be prepared 
in elective cases. Two units of whole blood un- 
dergo plasmapheresis, yield 25 to 40 ml. of the 
concentrate, and the red blood cells can be 
reinfused during surgery. The process requires 
ten days’ lead time but totally eliminates the risk 
of hepatitis. However, 40 ml. may not be 
sufficient for cases involving a large renal pelvis. 
Cryoprecipitate, commercial bovine thrombin, 
and calcium chloride are sterile products. 
The risk of introducing infection is low since 
sterility can be maintained by a series of sterile 
syringe exchanges from product container to 
waterbath to operative field. The cost of cryo- 
precipitate is not prohibitive, about $11 per 
packet which contains 15 to 20 ml. The number 
of packets needed will depend on the measured 
collecting system volume, but a minimum of 
four on hand is advised. 
Our operative technique employs a single 
angiocatheter in the renal pelvis, premixing of 
the constituent solutions, and represents a 
simplification of previously described operative 
methods where one or two larger catheters are 
sutured into separate pyelotomies. With our 
modifications there is less renal dissection, the 
operative time is not prolonged, and premixing 
ensures more complete admixture with greater 
likelihood of calculi entrapment. Should the 
coagulum fail to remove the stones, other pro- 
cedures still can be employed with no signifi- 
cant increase in difficulty or time lost. 
should be injected into a closed system. This 
requirement is not absolute. However, if a prior 
pyelotomy or nephrotomy has been made, it 
should be closed in a watertight manner before 
injecting the solution. 
The cryoprecipitate can be colored to pro- 
mote delineation of the coagulum from the 
collecting system. We did this by adding 0.5.~~. 
of methylene blue to the syringe containing the 
cryoprecipitate in 16 of our cases and found it to 
be helpful. When firm, the coagulum is opales- 
cent, and an intraoperative radiograph should 
always be obtained to verify extraction of all 
calculi. 
Certainly the key to successful use of the 
coagulum as a primary procedure is careful case 
selection with emphasis on calyceal structure. 
Limitations of the coagulum are entirely ana- 
tomic. It may not work as the sole maneuver 
for stone removal if there is an intrarenal 
pelvis with limited or no pyelocalyceal dilata- 
tion, or if stenotic infundibula drain calyces 
that contain larger calculi. However, even 
when the aforementioned anatomic circum- 
stances do exist, injection of the coagulant 
can be combined with a standard stone pro- 
cedure and be extremely beneficial. It will 
remove free-floating fragments, calculi, and 
sediment that are present or are created in the 
course of such calculi manipulations as in ex- 
tended pyelolithotomy, segmental or anatrophic 
nephrolithotomy. Certainly our experience to 
date would support this. 
W’e would hope that the availability of the 
cryoprecipitate blood product, the consistent 
formulation, the safety of the procedure with a 
less complex injection technique, and its 
successful use in several different forms of 
upper tract calculus disease would encourage 
general clinical application. 
3075 W. Clark Road 
Ypsilanti, Michigan 48197 
(DR. FISCHER) 
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